TTR and cardiac amyloidosis: Additionally, treatments for cardiac amyloidosis 164 include transthyretin amyloidosis (ATTR) stabilizers that prevent tetramer dissociation and amyloid formation, such as tafamidis 165, which can reduce TTR production through RNA silencing.